NO20030794L - Fremgangsmåte for legemiddelavlevering til hepatocytter av flavivirida-infeksjoner - Google Patents

Fremgangsmåte for legemiddelavlevering til hepatocytter av flavivirida-infeksjoner

Info

Publication number
NO20030794L
NO20030794L NO20030794A NO20030794A NO20030794L NO 20030794 L NO20030794 L NO 20030794L NO 20030794 A NO20030794 A NO 20030794A NO 20030794 A NO20030794 A NO 20030794A NO 20030794 L NO20030794 L NO 20030794L
Authority
NO
Norway
Prior art keywords
flavivirida
hepatocytes
infections
drug delivery
drug
Prior art date
Application number
NO20030794A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030794D0 (no
Inventor
Lau Johnson
Zhi Hong
Original Assignee
Ribapharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribapharm Inc filed Critical Ribapharm Inc
Publication of NO20030794D0 publication Critical patent/NO20030794D0/no
Publication of NO20030794L publication Critical patent/NO20030794L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030794A 2000-08-22 2003-02-20 Fremgangsmåte for legemiddelavlevering til hepatocytter av flavivirida-infeksjoner NO20030794L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22686900P 2000-08-22 2000-08-22
US24062700P 2000-10-13 2000-10-13
PCT/US2001/026057 WO2002015904A1 (en) 2000-08-22 2001-08-21 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections

Publications (2)

Publication Number Publication Date
NO20030794D0 NO20030794D0 (no) 2003-02-20
NO20030794L true NO20030794L (no) 2003-04-22

Family

ID=26920944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030794A NO20030794L (no) 2000-08-22 2003-02-20 Fremgangsmåte for legemiddelavlevering til hepatocytter av flavivirida-infeksjoner

Country Status (15)

Country Link
EP (1) EP1313469A1 (pl)
JP (1) JP2004506684A (pl)
KR (1) KR20030040416A (pl)
CN (1) CN1447692A (pl)
AU (1) AU2001292557A1 (pl)
BR (1) BR0113388A (pl)
CA (1) CA2415793A1 (pl)
CZ (1) CZ2003308A3 (pl)
HU (1) HUP0302884A2 (pl)
IL (1) IL154167A0 (pl)
MX (1) MXPA03001529A (pl)
NO (1) NO20030794L (pl)
PL (1) PL365744A1 (pl)
RU (1) RU2003102607A (pl)
WO (1) WO2002015904A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037908A1 (en) * 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
US7608258B2 (en) 2002-04-13 2009-10-27 Allan Mishra Method for treatment of tendinosis using platelet rich plasma
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
US20100112081A1 (en) 2008-10-07 2010-05-06 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
EP3623364A1 (en) 2014-02-13 2020-03-18 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984396A (en) * 1971-06-01 1976-10-05 Icn Pharmaceuticals, Inc. 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters
US5959077A (en) * 1993-05-26 1999-09-28 Laboratori Balducci S.P.A. Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CN1447692A (zh) 2003-10-08
WO2002015904B1 (en) 2002-07-04
EP1313469A1 (en) 2003-05-28
MXPA03001529A (es) 2004-04-02
KR20030040416A (ko) 2003-05-22
WO2002015904A1 (en) 2002-02-28
PL365744A1 (pl) 2005-01-10
BR0113388A (pt) 2004-02-25
IL154167A0 (en) 2003-07-31
RU2003102607A (ru) 2004-07-27
CZ2003308A3 (cs) 2004-03-17
AU2001292557A1 (en) 2002-03-04
HUP0302884A2 (hu) 2003-12-29
CA2415793A1 (en) 2002-02-28
JP2004506684A (ja) 2004-03-04
NO20030794D0 (no) 2003-02-20

Similar Documents

Publication Publication Date Title
CY2013011I2 (el) Μεθοδος χορηγησης διφωσφονικων
NO20031165L (no) Preparat for transdermal levering av fentanyl
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
PT1253932E (pt) Composicoes farmaceuticas de toxina botulinica
DK1381351T3 (da) Fremgangsmåde til kontinuerlig fremstilling af inhalerbare medikamenter
DE60121953D1 (de) Herstellungsverfahren von arzneizubereitungen
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
NO20025592L (no) Kontinuerlig produksjon av farmasöytisk granulering
NO20071303L (no) Farmasoytiske preparater
ITTO20010008A0 (it) Formulazione farmaceutica
EE200300103A (et) Kontratseptsioonimeetod ja kontratseptiivi manustatav vorm
DK1524266T3 (da) Farmaceutisk sammensætning
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
EE200200393A (et) Glüburiidi ravimkoostis
IS6508A (is) Lyfjasamsetningar af glycogen fosfórýlasa lötum
SI1601359T1 (sl) Tekoče farmacevtske formulacije palonosetrona
ITMO20030201A1 (it) Sistema di infusione di soluzioni farmacologiche
IS6521A (is) Aðferð til að hreinsa gerjunarseyði
ATE311173T1 (de) Neues selbstemulgierendes arzneistoffverabreichungssystem
EE200300501A (et) Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
NO20030794D0 (no) Fremgangsmåter for legemiddelavlevering til hepatocytter og behandling av flavivirida-infeksjoner
EE200100544A (et) 15-lülilised 8a- ja 9a-laktaamid, nende valmistamismeetod ja farmatseutiline kompositsioon
DK1591122T3 (da) Fremgangsmåde til indgivelse af bisphosphonater
IS7958A (is) Aðferð til að framleiða metýl 2-dífenýlmetýlsúlfínýlasetat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application